Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment

Mohamed Abou-El-Enein1, Toni Cathomen2, Zoltán Ivics3

  • 1Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Berlin, Germany.

Cell Stem Cell
|October 7, 2017
PubMed